| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable soft capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable soft capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Sunitinib 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Sunitinib 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fingolimod (as fingolimod hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fingolimod (as fingolimod hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sunitinib 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely sunitinib 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sunitinib 12.5 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely sunitinib 12.5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cholic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cholic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cholic acid 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Cholic acid 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Larotrectinib (as larotrectinib sulfate) 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Larotrectinib (as larotrectinib sulfate) 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely larotrectinib (as larotrectinib sulfate) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely larotrectinib (as larotrectinib sulfate) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely entrectinib 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely entrectinib 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely entrectinib 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely entrectinib 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely avacopan 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely avacopan 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely trientine (as trientine hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely trientine (as trientine hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Acalabrutinib 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Acalabrutinib 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline (as lymecycline) 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline (as lymecycline) 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Isavuconazole (as isavuconazonium sulfate) 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Isavuconazole (as isavuconazonium sulfate) 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely diroximel fumarate 231 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely diroximel fumarate 231 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
| Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
| Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ibuprofen 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ibuprofen 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Methylphenidate hydrochloride 5 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 5 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely tafamidis 61 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely tafamidis 61 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Propiverine hydrochloride 30 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Propiverine hydrochloride 30 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely propiverine hydrochloride 45 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely propiverine hydrochloride 45 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Vinorelbine (as vinorelbine tartrate) 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vinorelbine (as vinorelbine tartrate) 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely colecalciferol 1.25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely colecalciferol 1.25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely colecalciferol 20 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely colecalciferol 20 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely colecalciferol 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely colecalciferol 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 3 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely budesonide 3 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fluconazole 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fluconazole 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Omega-3-acid ethyl esters 90 1 g oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Omega-3-acid ethyl esters 90 1 g oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
| Vinorelbine (as vinorelbine tartrate) 30 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
FHIR